Fenfluramine Treatment in Infantile Autism

Texas A&M University - Galveston, Galveston, Texas, United States
Journal of Nervous & Mental Disease (Impact Factor: 1.69). 11/1984; 172(10):604-12. DOI: 10.1097/00005053-198410000-00003
Source: PubMed


As part of a multicenter, collaborative project, response to fenfluramine was assessed in 10 autistic outpatients. After 4 months of treatment, blood serotonin concentrations decreased an average of 60 per cent and returned to pretreatment levels after 2 months on placebo. This reduction was accompanied by a decrease in certain behavioral symptoms, including motor activity, distractibility, and mood disturbances. Baseline evoked potential recordings indicated that autistic patients tended to have a larger amplitude of the P3 component to frequent tones as compared to age-matched controls. A tendency toward "normalization" of the P3 effect was observed during the medication trial and during the final placebo period. Treatment response was not related to initial serotonin levels, and no major clinical side effects were associated with fenfluramine.

1 Read
  • [Show abstract] [Hide abstract]
    ABSTRACT: Various theories have been provided in the literature regarding the etiology of infantile autism. It seems that the biological causation dominates the thinking of mental health practitioners and researchers irrespective of discipline. Areas of research include the following: neuropathological studies of the brain, autopsies, electroencephalograms, epileptic seizures, brain lateralization, studies in asymmetry; neurochemistry; genetics; and pre-, peri- and postnatal factors. A critical analysis of these studies has indicated that the evidence of organic factors tends to be rather weak and furthermore has been found to be contradictory. It is felt that the major problem lies in the fact that a large number of investigators include in their sampling children with various mental and physical disabilities and label them autistic. In general, there seems to be little information regarding the selection and little background information is offered on these children. It is suggested that a standardized and world wide diagnostic system be constructed which will provide objective etiological results.
    International Journal of Neuroscience 10/1986; 30(3):195-225. DOI:10.3109/00207458608985670 · 1.52 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Fenfluramine was administered to subgroups of high and low functioning autistic outpatients using a double-blind, placebo-controlled crossover design. Blood serotonin concentrations decreased an average of 60% after 16 weeks on medication for all subjects regardless of premedication concentrations. Reductions in hyperactivity and motor symptoms and improved attention were noted in both patient subgroups. Improved social awareness was seen only in high functioning autistic patients. No significant improvements were observed in intellectual functioning, nor were there any meaningful changes in clinician ratings of primary autistic disturbances.
    Journal of the American Academy of Child & Adolescent Psychiatry 06/1987; 26(3):342-6. DOI:10.1097/00004583-198705000-00011 · 7.26 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Visual event-related potentials were recorded from five male autistics and five matched controls. Sensory effects were investigated by having subjects passively view flashes of three different but equiprobable intensities (augmenting/reducing paradigm). Cognitive effects were examined by having subjects count infrequent, target, flashes of one intensity embedded within a series of frequent, nontarget, flashes of a different intensity (oddball paradigm). In the augmenting/reducing paradigm, the sensory N100 wave of autistic but not controls showed a significant increase in amplitude (augmenting) as flash intensity increased. The cognitive P300 wave of autistics did not differ from controls in the oddball paradigm. Unlike controls, autistics had an equally large P300 in the no-task augmenting/reducing paradigm. It is concluded that autistics may experience a degree of stimulus overload in the visual modality.
    Journal of Autism and Developmental Disorders 07/1987; 17(2):231-42. DOI:10.1007/BF01495058 · 3.34 Impact Factor
Show more